Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -100.00% and Operating profit at -3.07% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -11.71
2
Flat results in Dec 24
3
Risky -
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.0%
0%
-26.0%
6 Months
-23.09%
0%
-23.09%
1 Year
3.82%
0%
3.82%
2 Years
-74.33%
0%
-74.33%
3 Years
-89.14%
0%
-89.14%
4 Years
-89.8%
0%
-89.8%
5 Years
-90.25%
0%
-90.25%
Sequana Medical NV for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-3.07%
EBIT to Interest (avg)
-11.71
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
0.03
Tax Ratio
1.33%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.02
EV to EBIT
-4.07
EV to EBITDA
-4.33
EV to Capital Employed
-12.62
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
0.70
0.90
-22.22%
Operating Profit (PBDIT) excl Other Income
-28.80
-28.00
-2.86%
Interest
4.30
0.90
377.78%
Exceptional Items
0.00
-1.30
100.00%
Consolidate Net Profit
-32.60
-30.80
-5.84%
Operating Profit Margin (Excl OI)
-41,421.30%
-31,203.50%
-1,021.78%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -22.22% vs 125.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -5.84% vs -30.51% in Dec 2022
About Sequana Medical NV 
Sequana Medical NV
Pharmaceuticals & Biotechnology
Sequana Medical NV is a Belgium-based company, which manufactures medical devices. The Company focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
Company Coordinates 
Company Details
Technologiepark 122, Zwijnaarde , GENT None : 9052
Registrar Details






